Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT(312 views) Varrone A, Soricelli A, Postiglione A, Salvatore M
Affiliations: Ctr. Nucl. Med. Natl. Res. Cncl., University Federico II, Naples, Italy
Dept. Biomorphological Funct. Studs., University Federico II, Naples, Italy
Ctro. per la Med. Nucleare del CNR, Università Federico II, Via Pansini, 5-80131 Napoli, Italy
References: Johnson, K.A., Mueller, S.T., Walshe, T.M., English, R.J., Holman, B.L., Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine 1-123 (1987) Arch Neurol, 44, p. 16
Holman, B.L., Johnson, K.A., Gerada, B., Carvalho, P.A., Satlin, A., The scintigraphic appearance of Alzheimer's disease: A prospective study using Technetium-99m-HMPAO-SPECT (1992) J Nucl Med, 33, p. 181
Johnson, K.A., Kijewski, M.F., Becker, A., Quantitative brain SPECT in Alzheimer's disease and normal aging (1993) J Nucl Med, 34, p. 2044
Messa, C., Perani, D., Lucignani, G., High-resolution Technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: Comparison with fluorine-18-FDG PET (1994) J Nucl Med, 35, p. 210
Rapoport, S.I., Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review (1991) Cerebrovascular and Brain Metabolism Reviews, 3, p. 297
De Kosky, S.T., Bass, N.H., Biochemistry of senile dementia (1985) Handbook of Neurochemistry, pp. 617-649. , Laitha A, ed. New York: Plenum Press
Selkoe, D.J., Aging, amyloid, and Alzheimer's disease (1989) N Engl J Med, 320, p. 1484
Terry, R.D., Peck, A., De Teresa, R., Schlechter, R., Horoupian, D.S., Some morphometric aspects of the brain in senile dementia of the Alzheimer type (1981) Ann Neurol, 10, p. 184
Yamaguchi, F., Hirai, S., Morimatso, M., A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by β-protein immunostaining (1988) Acta Neuropathol, 76, p. 541
Karbe, H., Kertesz, A., Davis, J., Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for Tc-99m-HMPAO SPECT (1994) Neuroradiology, 36, p. 1
O'Brien, J.T., Eagger, S., Syed, G.M.S., Sahakian, B.J., Levy, R., A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease (1992) J Neurol Neurosurg Psychiatry, 55, p. 1182
Cohen, D., Krausz, Y., Lossos, A., Ben-David, E., Atlan, H., Brain SPECT imaging with Tc-99m HM-PAO in Creutzfeld-Jakob disease (1989) Clin Nucl Med, 14, p. 808
Grunwald, F., Zierz, S., Broich, K., HMPAO-SpECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) (1990) J Nucl Med, 31, p. 1740
Kuwabara, Y., Ichiya, Y., Otsuka, M., Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging (1990) Clin Nucl Med, 15, p. 893
Innis, R., Zoghbi, S., Johnson, E., SPECT imaging of the benzodiazepine receptor in non-human primate brain with [I-123]Ro 16-0154 (1991) Eur J Pharmacol, 193, p. 249
Woods, S.W., Seibyl, J.P., Goddard, A.W., Dynamic SPECT imaging after the injection of the benzodiazepine receptor ligand [I-123]iomazenil in healthy human subjects (1992) Psychiatry Res Neuroimaging, 45, p. 67
Abi-Dargham, A., Laurelle, M., Seibyl, J., SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: Kinetic and equilibrium paradigms (1994) J Nucl Med, 35, p. 228
Abi-Dargham, A., Gandelman, M., Zoghbi, S.S., Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodinc-123-iomazcnil (1995) J Nucl Med, 36, p. 167
Soricelli, A., Postiglione, A., Grivet-Fojaia, M.R., Preliminary evaluation of distribution volume for 123-I-iomazenil in Alzheimer's disease as a measure of loss of synapses (1996) Eur J Nucl Med, 23, p. 1323
Fukuchi, K., Hashikawa, K., Seike, Y., Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease (1997) J Nucl Med, 38, p. 467
Onishi, Y., Yonekura, Y., Takao, M., Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans (1995) J Nucl Med, 36, p. 1201
McKhann, G., Drachman, D., Folstein, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease (1984) Neurology, 34, p. 939
Hachinski, V.C., Iliff, L.D., Zilhka, E., Cerebral blood flow in dementia (1975) Arch Neurol, 32, p. 632
Reisberg, B., Ferris, S.H., De Leon, M.J., Crook, T., The global deterioration scale for assessment of primary degenerative dementia (1982) Am J Psychiatry, 139, p. 1136
Folstein, M.F., Folstein, S.E., McHugh, P.R., Mini-mental state: A pratical method for grading the cognitive state of patients for the clinician (1975) J Psychiatr Res, 12, p. 189
Genna, S., Smith, A.P., The development of ASPECT, an annular single crystal brain camera for high efficiency SPECT (1988) IEEE Trans Nucl Sci, 35, p. 654
Chang, L.-T., A method for attenuation correction in radionuclide computed tomography (1978) IEEE Trans Nucl Sci, 25, p. 638
Lassen, N.A., Andersen, A.R., Friberg, L., Paulson, O.B., The retention of [Tc-99m]-d,l,-HMPAO in the human brain after intracarotid bolus injection: A kinetic analysis (1988) J Cereb Blood Flow Metab, 8, pp. S13
Neirinckx, R.D., Burke, J.F., Harrison, R.C., The retention mechanism of technetium-99m-HMPAO: Intracellular reaction with glutathione (1988) J Cereb Blood Flow Metab, 8, pp. S4
Payne, J.K., Trivedi, M.H., Devous, M.D., Comparison of technetium-99m-HMPAO and Xenon-133 measurements of regional cerebral blood flow by SPECT (1996) J Nucl Med, 37, p. 1735
Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT
Purpose: To compare brain perfusion and synaptic density in Alzheimer's disease assessed using I-123 iomazenil SPECT with brain perfusion assessed using Tc-99m HMPAO SPECT. Materials and Methods: Early and delayed I-123 iomazenil SPECT images acquired 20 and 180 minutes after injection were compared with Tc-99m HMPAO SPECT studies acquired 15 to 20 minutes after injection in five patients with Alzheimer's disease. Results: Visual analysis of I-123 iomazenil images showed more severe (n = 4) and extensive (n = 3) defects than did Tc-99m HMPAO. Semiquantitative analysis was performed by normalizing the uptake of Tc-99m HMPAO and I-123 iomazenil in individual brain regions in the cerebellum and expressing these values as a ratio of the occipital regions. The analysis of brain regional ratios in Tc-99m HMPAO studies showed a low but significant correlation with ratios of delayed (r = 0.325, P < 0.05) images in the I-123 iomazenil studies. Furthermore, when compared with Tc-99m HMPAO, early (P < 0.01) and delayed mean ratios (P < 0.05) were significantly less in the frontal regions; early mean ratios were significantly less in the temporal regions (P < 0.05), and delayed (P < 0.05) mean ratios were significantly less in the parietal regions. Conclusions: Tc-99m HMPAO images were better correlated with I-123 iomazenil images, indicating cortical synaptic density (delayed images). I-123 iomazenil SPECT in patients with Alzheimer's disease provided more sensitive information than Tc-99m HMPAO, allowing evaluation of brain perfusion and synaptic density.
Comparison between cortical distribution of I-123 lomazenil and Tc-99m HMPAO in patients with Alzheimer's disease using SPECT
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(496 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(834 views) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(694 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote